Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.
2-Mar-2017 8:00 AM EST Add to Favorites
Ludwig researchers discover that circular DNA, once thought to be rare in tumor cells, is actually very common and seems to play a fundamental role in tumor evolution
8-Feb-2017 1:05 PM EST Add to Favorites
Findings uncover an ancient mechanism that makes cancer cells invasive, explains melanoma’s resistance to therapy and opens the door to development of novel cancer therapies
16-Jan-2017 5:00 PM EST Add to Favorites
It is with great pleasure that the Ludwig Institute for Cancer Research announces the appointment of Chi Van Dang as its Scientific Director.
20-Dec-2016 12:00 PM EST Add to Favorites
The Ludwig Institute for Cancer Research extends a warm welcome to Barbara S. Jones, the newest member of our Board of Directors.
7-Dec-2016 9:00 AM EST Add to Favorites
A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body’s immune system from attacking tumors.
9-Nov-2016 2:00 PM EST Add to Favorites
A Ludwig Cancer Research study published in the current issue of Scientific Reports describes a new method and risk model to assess how aggressive a bladder cancer is likely to be. “If confirmed in larger studies, our findings could help...
23-Oct-2016 8:00 PM EDT Add to Favorites
Ludwig Researchers Show How a Brain Tumor’s Greed for Cholesterol Could Be Exploited for Cancer Therapy
A Ludwig Cancer Research study has identified a metabolic vulnerability in the aggressive and incurable brain cancer glioblastoma (GBM) and shown how it can potentially be exploited for therapy.
11-Oct-2016 12:45 PM EDT Add to Favorites